Your browser doesn't support javascript.
loading
Publisher Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.
Koeberl, Dwight; Schulze, Andreas; Sondheimer, Neal; Lipshutz, Gerald S; Geberhiwot, Tarekegn; Li, Lerong; Saini, Rajnish; Luo, Junxiang; Sikirica, Vanja; Jin, Ling; Liang, Min; Leuchars, Mary; Grunewald, Stephanie.
Afiliação
  • Koeberl D; Duke University School of Medicine, Durham, NC, USA.
  • Schulze A; Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
  • Sondheimer N; Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
  • Lipshutz GS; University of California at Los Angeles (UCLA), Los Angeles, CA, USA.
  • Geberhiwot T; University of Birmingham, Birmingham, UK.
  • Li L; Moderna, Inc., Cambridge, MA, USA.
  • Saini R; Moderna, Inc., Cambridge, MA, USA.
  • Luo J; Moderna, Inc., Cambridge, MA, USA.
  • Sikirica V; Moderna, Inc., Cambridge, MA, USA.
  • Jin L; Moderna, Inc., Cambridge, MA, USA.
  • Liang M; Moderna, Inc., Cambridge, MA, USA.
  • Leuchars M; Moderna, Inc., Cambridge, MA, USA.
  • Grunewald S; Great Ormond Street Hospital for Children and Institute for Child Health, NIHR Biomedical Research Centre, London, UK. Stephanie.Grunewald@gosh.nhs.uk.
Nature ; 630(8017): E13, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38844679
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article